Clinical ink Selected for Global Late Phase Parkinson’s Disease Programs
15 déc. 2022 08h42 HE
|
Clinical Ink
Horsham, PA, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, has partnered with a leading biopharmaceutical organization focused on Parkinson’s Disease...